Bank of America Corp DE Lowers Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Posted by Geri Gentry on Aug 8th, 2026

Bank of America Corp DE lessened its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) by 8.4% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,409,161 shares of the real estate investment trust’s stock after selling 493,377 shares during the period. Bank of America Corp DE’s holdings in Sabra Healthcare REIT were worth $104,018,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Amundi lifted its position in Sabra Healthcare REIT by 22.7% during the 1st quarter. Amundi now owns 182,620 shares of the real estate investment trust’s stock worth $3,512,000 after acquiring an additional 33,787 shares during the period. EverSource Wealth Advisors LLC raised its stake in shares of Sabra Healthcare REIT by 21.0% during the first quarter. EverSource Wealth Advisors LLC now owns 4,708 shares of the real estate investment trust’s stock worth $91,000 after purchasing an additional 817 shares during the last quarter. California State Teachers Retirement System raised its stake in shares of Sabra Healthcare REIT by 32.2% during the first quarter. California State Teachers Retirement System now owns 298,653 shares of the real estate investment trust’s stock worth $5,743,000 after purchasing an additional 72,721 shares during the last quarter. Rush Island Management LP acquired a new stake in shares of Sabra Healthcare REIT during the first quarter worth $30,735,000. Finally, Quantinno Capital Management LP lifted its holdings in shares of Sabra Healthcare REIT by 424.3% during the first quarter. Quantinno Capital Management LP now owns 155,086 shares of the real estate investment trust’s stock worth $2,982,000 after purchasing an additional 125,507 shares during the period. 99.40% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Wells Fargo & Company boosted their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Raymond James Financial upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday. Barclays began coverage on shares of Sabra Healthcare REIT in a report on Tuesday, July 7th. They set an “overweight” rating and a $21.00 price target for the company. Finally, Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Seven investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and a consensus price target of $22.25.

Check Out Our Latest Report on SBRA

Sabra Healthcare REIT Stock Performance

NASDAQ:SBRA opened at $21.04 on Friday. The company has a quick ratio of 4.72, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. Sabra Healthcare REIT, Inc. has a fifty-two week low of $17.17 and a fifty-two week high of $22.77. The stock has a market cap of $5.37 billion, a PE ratio of 80.93, a price-to-earnings-growth ratio of 1.62 and a beta of 0.64. The firm’s fifty day simple moving average is $19.82 and its 200-day simple moving average is $19.98.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last announced its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The company had revenue of $230.11 million during the quarter, compared to analyst estimates of $219.39 million. During the same quarter last year, the business earned $0.38 EPS. The firm’s revenue for the quarter was up 24.7% on a year-over-year basis. Analysts expect that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 5.7%. Sabra Healthcare REIT’s payout ratio is 461.54%.

Sabra Healthcare REIT Profile

(Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.